RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/25053409http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/25053409http://www.w3.org/2000/01/rdf-schema#comment"Rapamycin at high doses (2-10 mg/kg body weight) inhibits mammalian target of rapamycin complex 1 (mTORC1) and protein synthesis in mice. In contrast, low doses of rapamycin (10 μg/kg) increase mTORC1 activity and protein synthesis in skeletal muscle. Similar changes are found with SLF (synthetic ligand for FKBP12, which does not inhibit mTORC1) and in mice with a skeletal muscle-specific FKBP12 deficiency. These interventions also increase Ca(2+) influx to enhance refilling of sarcoplasmic reticulum Ca(2+) stores, slow muscle fatigue, and increase running endurance without negatively impacting cardiac function. FKBP12 deficiency or longer treatments with low dose rapamycin or SLF increase the percentage of type I fibers, further adding to fatigue resistance. We demonstrate that FKBP12 and its ligands impact multiple aspects of muscle function."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.org/dc/terms/identifier"doi:10.1074/jbc.m114.586289"xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Long C."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Xu J."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Lee C.S."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Tran T."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Ji R."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Knoblauch M."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Georgiou D.K."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Hamilton S.L."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Monroe T.O."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Ismailov I.I."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Bayle J.H."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Joshi A.D."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Lanner J.T."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Ingalls C.P."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Durham W.J."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Narkar V.A."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Oakes J."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Corona B.T."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Hanna A.D."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Lorca S."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/author"Dagnino-Acosta A."xsd:string
http://purl.uniprot.org/citations/25053409http://purl.uniprot.org/core/date"2014"xsd:gYear